Skip to main content

MJFF Publications

3321 - 3330 of 7616 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • RESTRICTED
    Title: Dopamine imaging in prodromal Parkinson disease trials
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000010957
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-020-00139-6
    Citation Count: 20
  • RESTRICTED
    Title: Cortical volume abnormalities in posttraumatic stress disorder: an ENIGMA-psychiatric genomics consortium PTSD workgroup mega-analysis
    Journal Name: Molecular Psychiatry
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41380-020-00967-1
    Citation Count: 61
  • RESTRICTED
    Title: Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.12240
    Citation Count: 14
  • RESTRICTED
    Title: The Future of GDNF in Parkinson's Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2020.593572
    Citation Count: 31
  • RESTRICTED
    Title: A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson’s disease ‘OFF’ episodes
    Journal Name: Expert Review of Neurotherapeutics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14737175.2020.1855145
    Best OA location URL:
    Citation Count: 9
  • RESTRICTED
    Title: Developing new treatments in partnership for primary mitochondrial disease: What does industry need from academics, and what do academics need from industry?
    Journal Name: Journal of Inherited Metabolic Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/jimd.12326
    Best OA location URL:
    Citation Count: 2
  • RESTRICTED
    Title: Apathy and Anxiety in De Novo Parkinson's Disease Predict the Severity of Motor Complications
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13117
    Citation Count: 12
  • RESTRICTED
    Title: Pedunculopontine Nucleus Deep Brain Stimulation for Parkinsonian Disorders: A Case Series
    Journal Name: Stereotactic and Functional Neurosurgery
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1159/000511978
    Citation Count: 13
  • RESTRICTED
    Title: Review of computational approaches to Parkinson’s disease gene prediction
    Journal Name: 2020 3rd International Conference on Intelligent Sustainable Systems (ICISS)
    Publisher: IEEE
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1109/iciss49785.2020.9315926
    Best OA location URL:
    Citation Count: 0
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.